SEC Filings

SEC Filings

Filing date	Description	Form	Company	View
May 09, 2019	Report of unscheduled material events or corporate event	8-K	Surface Oncology	0001564590-19-017525.pdf 0001564590-19-017525.rtf 0001564590-19-017525.xls View HTML
May 09, 2019	Quarterly report which provides a continuing view of a company's financial position	10-Q	Surface Oncology	0001564590-19-017527.pdf 0001564590-19-017527.rtf 0001564590-19-017527.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
May 08, 2019	EFFECT	EFFECT	Surface Oncology	9999999995-19-001053.pdf 9999999995-19-001053.rtf View HTML
May 02, 2019	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-19-026968.pdf 0001209191-19-026968.rtf View HTML
May 01, 2019	Simplified registration form	S-3	Surface Oncology	0001193125-19-130940.pdf 0001193125-19-130940.rtf 0001193125-19-130940.xls View HTML
Apr 19, 2019	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	Surface Oncology	0001564590-19-012062.pdf 0001564590-19-012062.rtf 0001564590-19-012062.xls View HTML
Apr 19, 2019	Additional proxy soliciting materials - definitive	DEFA14A	Surface Oncology	0001564590-19-012063.pdf 0001564590-19-012063.rtf 0001564590-19-012063.xls View HTML
Apr 02, 2019	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-19-022728.pdf 0001209191-19-022728.rtf View HTML
Apr 01, 2019	Initial filing by director officer or owner of more than ten percent.	3	Surface Oncology	0001209191-19-021978.pdf 0001209191-19-021978.rtf View HTML
Mar 07, 2019	Report of unscheduled material events or corporate event	8-K	Surface Oncology	0001564590-19-006767.pdf 0001564590-19-006767.rtf 0001564590-19-006767.xls View HTML

Copyright Morningstar